Skip to content
10-Q

Quarterly Report

UTAH MEDICAL PRODUCTS INC UTMD

0001811884-24-000018

← back to feed
Filed
Aug 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 8, 2024 3.48M sh
Cash And Equivalents Q2 2024 · Jun 30, 2024 $89.22M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $92.87M
Stockholders Equity Q2 2024 · Jun 30, 2024 $124.05M
Stockholders Equity Q2 2024 · Dec 31, 2023 $128.31M
Current Liabilities Q2 2024 · Jun 30, 2024 $3.94M
Current Liabilities Q2 2024 · Dec 31, 2023 $4.71M
Total Liabilities Q2 2024 · Jun 30, 2024 $5.98M
Total Liabilities Q2 2024 · Dec 31, 2023 $7.15M
Current Assets Q2 2024 · Jun 30, 2024 $102.32M
Current Assets Q2 2024 · Dec 31, 2023 $106.27M
Total Assets Q2 2024 · Jun 30, 2024 $130.03M
Total Assets Q2 2024 · Dec 31, 2023 $135.46M
Shares Diluted Q2 2024 · Jun 30, 2023 3.64M sh
Shares Diluted Q2 2024 · Jun 30, 2023 3.64M sh
Stock Repurchased Q2 2024 · Jun 30, 2023 $0
Dividends Paid Q2 2024 · Jun 30, 2023 $2.14M
Capex Q2 2024 · Jun 30, 2023 $363K
Operating Cash Flow Q2 2024 · Jun 30, 2023 $11.83M
Eps Diluted Q2 2024 · Jun 30, 2023 $1.15
Eps Diluted Q2 2024 · Jun 30, 2023 $2.31
Eps Basic Q2 2024 · Jun 30, 2023 $1.16
Eps Basic Q2 2024 · Jun 30, 2023 $2.32
Sga Expense Q2 2024 · Jun 30, 2023 $3.18M
Sga Expense Q2 2024 · Jun 30, 2023 $6.44M
Rd Expense Q2 2024 · Jun 30, 2023 $133K
Rd Expense Q2 2024 · Jun 30, 2023 $277K
Net Income Q2 2024 · Jun 30, 2023 $4.2M
Net Income Q2 2024 · Jun 30, 2023 $8.41M
Net Income Q2 2024 · Mar 31, 2023 $4.21M
Operating Income Q2 2024 · Jun 30, 2023 $4.43M
Operating Income Q2 2024 · Jun 30, 2023 $8.86M
Gross Profit Q2 2024 · Jun 30, 2023 $7.74M
Gross Profit Q2 2024 · Jun 30, 2023 $15.58M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $5.13M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $9.81M
Revenue Q2 2024 · Jun 30, 2023 $12.87M
Revenue Q2 2024 · Jun 30, 2023 $25.39M